Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2013, Article ID 269165, 8 pages
http://dx.doi.org/10.1155/2013/269165
Research Article

Anti-Tumor Effect of Rutin on Human Neuroblastoma Cell Lines through Inducing G2/M Cell Cycle Arrest and Promoting Apoptosis

1Beijing Key Laboratory for Aging and Geriatrics, Institute of Geriatrics, General Hospital of Chinese PLA, Beijing, China
2National Institute of Occupational Health and Poison Control, Chinese Center for Disease Control and Prevention, Beijing, China
3Minzu University of China, Beijing, China

Received 14 October 2013; Accepted 7 November 2013

Academic Editors: C.-L. Hsieh, B.-Y. Zeng, and K. Zhao

Copyright © 2013 Hongyan Chen et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. M. Maris, “Recent advances in neuroblastoma,” The New England Journal of Medicine, vol. 362, no. 23, pp. 2154–2211, 2010. View at Google Scholar · View at Scopus
  2. S. Mueller and K. K. Matthay, “Neuroblastoma: biology and staging,” Current Oncology Reports, vol. 11, no. 6, pp. 431–438, 2009. View at Publisher · View at Google Scholar · View at Scopus
  3. L. Jia, S. Ma, X. Hou et al., “The synergistic effects of traditional Chinese herbs and radiotherapy for cancer treatment,” Oncology Letters, vol. 5, no. 5, pp. 1439–1447, 2013. View at Google Scholar
  4. S. H. Nile and S. W. Park, “Edible berries: review on bioactive components and their effect on human health,” Nutrition, 2013. View at Publisher · View at Google Scholar
  5. H. Hoensch and R. Oertel, “Anti-inflammatory effects of tea-flavonoids,” Deutsche Medizinische Wochenschrift, vol. 137, no. 51-52, pp. 2738–2740, 2012. View at Google Scholar
  6. M. S. Geybels, B. A. Verhage, I. C. Arts, F. J. van Schooten, R. A. Goldbohm, and P. A. van den Brandt, “Dietary flavonoid intake, black tea consumption, and risk of overall and advanced stage prostate cancer,” American Journal of Epidemiology, vol. 177, no. 12, pp. 1388–1398, 2013. View at Google Scholar
  7. K. Evans, “Flavonoids in fruits, vegetables and nuts dramatically lower cancer rates,” Tags: cancer, flavonoids, health news, September 2011.
  8. H. J. Chan, Y. L. Ji, H. C. Chul, and J. K. Chang, “Anti-asthmatic action of quercetin and rutin in conscious guinea-pigs challenged with aerosolized ovalbumin,” Archives of Pharmacal Research, vol. 30, no. 12, pp. 1599–1607, 2007. View at Google Scholar · View at Scopus
  9. S. R. Volate, D. M. Davenport, S. J. Muga, and M. J. Wargovich, “Modulation of aberrant crypt foci and apoptosis by dietary herbal supplements (quercetin, curcumin, silymarin, ginseng and rutin),” Carcinogenesis, vol. 26, no. 8, pp. 1450–1456, 2005. View at Publisher · View at Google Scholar · View at Scopus
  10. G. Yue, J. Wei, X. Qian et al., “Synergistic anticancer effects of polyphyllin and evodiamine on freshly-removed human gastric tumors,” PLoS ONE, vol. 8, no. 6, Article ID e65164, 2013. View at Publisher · View at Google Scholar
  11. X. Yan, T. Lyu, N. Jia, Y. Yu, K. Hua, and W. Feng, “Huaier aqueous extract inhibits ovarian cancer cell motility via the AKT/GSK3β/β-catenin pathway,” PLoS ONE, vol. 8, no. 5, Article ID e63731, 2013. View at Publisher · View at Google Scholar
  12. A. Hunyadi, A. Martins, T. J. Hsieh, A. Seres, and I. Zupkó, “Chlorogenic acid and rutin play a major role in the in vivo anti-diabetic activity of Morus alba leaf extract on type II diabetic rats,” PLoS ONE, vol. 7, no. 11, Article ID e50619, 2012. View at Publisher · View at Google Scholar
  13. S. Sharma, A. Ali, J. Ali, J. K. Sahni, and S. Baboota, “Rutin: therapeutic potential and recent advances in drug delivery,” Expert Opinion on Investigational Drugs, vol. 22, no. 8, pp. 1063–1079, 2013. View at Google Scholar
  14. M. Majewska-Wierzbicka and H. Czeczot, “Anticancer activity of flavonoids,” Polski Merkuriusz Lekarski, vol. 33, no. 198, pp. 364–369, 2012. View at Google Scholar
  15. Y. Zhao, W. Jiang, B. Li et al., “Artesunate enhances radiosensitivity of human non-small cell lung cancer A549 cells via increasing NO production to induce cell cycle arrest at G2/M phase,” International Immunopharmacology, vol. 11, no. 12, pp. 2039–2046, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. M. Zhang, P. Zhang, C. Zhang et al., “Prognostic significance of Bcl-2 and Bax protein expression in the patients with oral squamous cell carcinoma,” Journal of Oral Pathology and Medicine, vol. 38, no. 3, pp. 307–313, 2009. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Faggiano, J.-C. Sabourin, M. Ducreux et al., “Pulmonary and extrapulmonary poorly differentiated large cell neuroendocrine carcinomas: diagnostic and prognostic features,” Cancer, vol. 110, no. 2, pp. 265–274, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Kulbe, R. Thompson, J. L. Wilson et al., “The inflammatory cytokine tumor necrosis factor-α generates an autocrine tumor-promoting network in epithelial ovarian cancer cells,” Cancer Research, vol. 67, no. 2, pp. 585–592, 2007. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Eilers and R. N. Eisenman, “Myc's broad reach,” Genes and Development, vol. 22, no. 20, pp. 2755–2766, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. N. Meyer and L. Z. Penn, “Reflecting on 25 years with MYC,” Nature Reviews Cancer, vol. 8, no. 12, pp. 976–990, 2008. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Vita and M. Henriksson, “The Myc oncoprotein as a therapeutic target for human cancer,” Seminars in Cancer Biology, vol. 16, no. 4, pp. 318–330, 2006. View at Publisher · View at Google Scholar · View at Scopus
  22. M. Huang and W. A. Weiss, “Neuroblastoma and MYCN,” Cold Spring Harbor Perspectives in Medicine, vol. 3, no. 10, Article ID 014415, 2013. View at Google Scholar
  23. A. Edsjö, L. Holmquist, and S. Påhlman, “Neuroblastoma as an experimental model for neuronal differentiation and hypoxia-induced tumor cell dedifferentiation,” Seminars in Cancer Biology, vol. 17, no. 3, pp. 248–256, 2007. View at Publisher · View at Google Scholar · View at Scopus
  24. U. K. Westermark, M. Wilhelm, A. Frenzel, and M. A. Henriksson, “The MYCN oncogene and differentiation in neuroblastoma,” Seminars in Cancer Biology, vol. 21, no. 4, pp. 256–266, 2011. View at Publisher · View at Google Scholar · View at Scopus